FKBP14 Antikörper (AA 20-211)
Kurzübersicht für FKBP14 Antikörper (AA 20-211) (ABIN7162819)
Target
Alle FKBP14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 20-211
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Peptidyl-prolyl cis-trans isomerase FKBP14 protein (20-211AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- FKBP14 (FK506 Binding Protein 14, 22 KDa (FKBP14))
-
Andere Bezeichnung
- FKBP14
-
Hintergrund
-
Background: PPIases accelerate the folding of proteins during protein synthesis.
Aliases: 22 kDa FK506 binding protein antibody, 22 kDa FK506-binding protein antibody, 22 kDa FKBP antibody, FK506 binding protein 14 (22 kDa) antibody, FK506 binding protein 14 antibody, FK506-binding protein 14 antibody, FKB14_HUMAN antibody, FKBP 22 antibody, FKBP-14 antibody, FKBP-22 antibody, FKBP14 antibody, FKBP22 antibody, FLJ20731 antibody, Peptidyl prolyl cis trans isomerase antibody, Peptidyl-prolyl cis-trans isomerase FKBP14 antibody, PPIase antibody, PPIase FKBP14 antibody, Rotamase antibody
-
UniProt
- Q9NWM8
-
Pathways
- ER-Nucleus Signaling
Target
-